HomeSite Map
AnVil
About AnVilSolutionsTechnologyNews and EventsContact
OverviewLeadership TeamInvestorsCareers

Investors

Company Brochure (.pdf)


Flagship Ventures

About Flagship Ventures:

Founded in 1999, Flagship Ventures is an entrepreneurship and venture capital firm comprised of a family of funds: OneLiberty Funds, AGTC Funds and NewcoGen Group. Flagship Ventures currently invests from $400 million in funds raised in 2000, and manages a total pool of committed capital approaching $600 million. The Flagship Ventures team consists of 30 professionals focused on creating, financing, and building companies in the life science, information technology, and communications sectors. Complementing their internal team is an extensive network of Advisor Partners who are actively engaged in evaluating - and often co-founding - new ventures. Flagship Ventures has founded over 20 successful new ventures while funding and building over 100 more.

To learn more about Flagship Ventures, visit their web site at http://www.flagshipventures.com.

Mason Wells

About Mason Wells:

Mason Wells began in 1982 as the merchant banking arm of the Marshall & Ilsley Corporation, the oldest existing bank operating in the Great Lakes Region with its origin dating to 1847. In 1998 Mason Wells was created as an independent management company to raise its first independent fund with capital provided by over twenty Midwest institutional investors and business partners. Mason Wells is currently managing over $350 million of investments in a wide range of companies in the biomedical and information technology fields.

To learn more about Mason Wells, visit their web site at http://www.masonwells.com.

Seaflower Ventures

About Seaflower Ventures:

Seaflower Ventures invests in promising, early-stage biomedical firms and considers seed and first-round investments in companies in most segments of the biomedical industry, including biotechnology, medical devices, healthcare information technology, and healthcare services. Seaflower currently manages three funds: The Seaflower Health & Technology Fund, L.L.C., a $5 million seed venture capital fund; the Seaflower BioVenture Fund II, L.L.C., a $10 million venture fund; and the J&L Sherblom Fund, L.L.C., a focused equity fund. Typical investments range from $250,000 to $1,250,000 for promising opportunities.

To learn more about Seaflower Ventures and review its portfolio of companies, visit their web site at http://www.seaflower.com.

back to top

 



AnVil has received financing from three leading venture capital firms: Flagship Ventures, Mason Wells Biomedical Fund, and Seaflower Ventures.

Copyright © 2002 AnVil, Inc. All rights reserved.
Created by PixelMEDIA, Inc.

sitemapoutdoor fireplace | infrared heater | kerosene heater | Prom Ball Gowns | forex trading signals outdoor fireplace | infrared heater | kerosene heater | Prom Ball Gowns | forex trading signals